Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 2433

BillFederalSenateIn Committee
To reauthorize certain programs under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, and for other purposes.
About This Bill
Committee
Latest Action · July 20, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
118th (2023–2025)
Introduced
July 20, 2023
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
SUPPORT for Patients and Communities Reauthorization Act of 2023 This bill reauthorizes through FY2028 programs and activities relating to mental health and substance use disorder services. Reauthorized programs and activities include programs that enable access to drugs or devices that temporarily reverse opioid overdoses,activities to support the capacity of laboratories to detect synthetic opioids (e.g., fentanyl),residential treatment programs for pregnant and postpartum individuals, andtraining and workforce development for providers of mental health and substance use disorder services.The bill also modifies certain requirements relating to the regulation of controlled substances and the provision of mental health and substance use disorder services, including by requiring (1) the issuance of federal guidance to support at-home safe disposal systems for drugs, (2) studies to evaluate the efficacy of opioid treatment through buprenorphine and methadone, and (3) evaluations of the use of certain block grants by states to treat individuals with serious mental illnesses.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.